The Popular Drug for Treatment of Asthma Is Now Under Investigation By The Fda Lethal Side Effects

Many asthmatics suddenly worried about taking SINGULAIR, popular allergy and asthma medication. SINGULAIR is now part of a safety review from the FDA for its possible link with suicide and depression. Doctors say adults and children still can continue taking the medication singular, but they have to look closely for signs of depression, behavioral disorders and suicidal tendencies.

SINGULAIR also known as montelukast is used for long-term maintenance treatment of asthma and to relieve symptoms of seasonal allergies. Although SINGULAIR has been associated with side effects such as gastrointestinal disorders, hypersensitivity reactions, sleep disorders and increased chance of major bleeding incidence of depression in users being investigated by the USA. Food and Drug Authority.

SINGULAIR sure it was successful drug for the treatment of asthma when introduced in 1998. This is a once-daily drug is offering free inhalers for asthma suffers as young as 6 years old . SINGULAIR, part of a new class called leukotriene inhibitors, was approved by the Food and Drug Administration in February 1998. It helps block the inflammatory response of the lung tissues, in part, the causes of asthma. The Food and Drug Administration in January 2003 approved the drug giant Merck asma Co SINGULAIR for use in the fight against hay fever (rhinitis), another common ailment. SINGULAIR is now widely prescribed to treat asthma and hay fever symptoms such as sneezing and stuffy nose is dripping or itching. Blocking the path of inflammation in the body that can cause both asthma and allergy symptoms. Medical experts say SINGULAIR is important for three reasons: Tests and showed some mild side effects, it is convenient and can be used in children as young as six years. The drug, however, did not treat asthma attacks. Asthmatics should still take your quick relief and rescue medications.

Merc the patentee and manufacturer of SINGULAIR is now working closely with USA. FDA last year to update the prescribing information and patient information for Singulair to include the possible risk of tremors, depression and suicidal tendencies.

approved asma, asma adults and children, asma asthmatics, asma disorders and suicidal, asma effects, asma experts, asma medications, asma reactions, asma symptoms, asma tendencies, associated asma, increased asma, introduced asma